Reaction
Arteriovenous Fistula Site Infection reporting signals
As of the last recalculation, Arteriovenous Fistula Site Infection appears in 134 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PARICALCITOL (PRR 171.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Paricalcitol | 14 | 171.8 | 172.0 |
| Sevelamer Carbonate | 7 | 99.8 | 99.9 |
| Darbepoetin Alfa | 25 | 88.3 | 88.4 |
| Cinacalcet Hydrochloride | 6 | 20.9 | 20.9 |